The place of sirolimus in kidney transplantation: Can we reduce calcineurin inhibitor renal toxicity?
- 1 September 2006
- journal article
- review article
- Published by Elsevier in Kidney International
- Vol. 70 (6) , 994-999
- https://doi.org/10.1038/sj.ki.5001644
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Complete Avoidance of Calcineurin Inhibitors in Renal Transplantation: A Randomized Trial Comparing Sirolimus and TacrolimusAmerican Journal of Transplantation, 2006
- Rapamycin for Treatment of Chronic Allograft Nephropathy in Renal Transplant PatientsJournal of the American Society of Nephrology, 2005
- Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantationTransplant International, 2004
- De Novo Kidney Transplantation Without Use of Calcineurin Inhibitors Preserves Renal Structure and Function at Two YearsAmerican Journal of Transplantation, 2004
- Sirolimus delays recovery of rat kidney transplants after ischemia-reperfusion injuryTransplantation, 2003
- Efficacy of sirolimus (rapamycin) administered concomitantly with a subtherapeutic dose of cyclosporin in the treatment of severe psoriasis: a randomized controlled trialBritish Journal of Dermatology, 2001
- IMMUNOSUPPRESSIVE EFFECTS AND SAFETY OF A SIROLIMUS/CYCLOSPORINE COMBINATION REGIMEN FOR RENAL TRANSPLANTATION1Transplantation, 1998
- EFFECT OF RAPAMYCIN ON MORPHOLOGICAL AND FUNCTIONAL PARAMETERS IN THE KIDNEY OF THE RABBITTransplantation, 1995
- THE EFFECT OF RAPAMYCIN ON KIDNEY FUNCTION IN THE SPRAGUE-DAWLEY RATTransplantation, 1992
- TOXICITY OF RAPAMYCIN—A COMPARATIVE AND COMBINATION STUDY WITH CYCLOSPORINE AT IMMUNOTHERAPEUTIC DOSAGE IN THE RATTransplantation, 1991